搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Nephroselmis olivacea NAD (P)H-quinone oxidoreductase subunit 4L, chloroplastic (ndhE), partial CSB-YP890547NDAA1
CSB-EP890547NDAA1
CSB-BP890547NDAA1
CSB-MP890547NDAA1
CSB-EP890547NDAA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nephroselmis olivacea NAD (P)H-quinone oxidoreductase chain 4, chloroplastic (ndhD), partial CSB-YP890548NDAA
CSB-EP890548NDAA
CSB-BP890548NDAA
CSB-MP890548NDAA
CSB-EP890548NDAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nephroselmis olivacea Sulfate/thiosulfate import ATP-binding protein cysA (cysA) CSB-YP890549NDAA
CSB-EP890549NDAA
CSB-BP890549NDAA
CSB-MP890549NDAA
CSB-EP890549NDAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nephroselmis olivacea Cytochrome b559 subunit beta (psbF), partial CSB-YP890550NDAA
CSB-EP890550NDAA
CSB-BP890550NDAA
CSB-MP890550NDAA
CSB-EP890550NDAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nephroselmis olivacea Cytochrome b6-f complex subunit 5 (petG), partial CSB-YP890551NDAA
CSB-EP890551NDAA
CSB-BP890551NDAA
CSB-MP890551NDAA
CSB-EP890551NDAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nephroselmis olivacea 30S ribosomal protein S7, chloroplastic (rps7) CSB-YP890552NDAA
CSB-EP890552NDAA
CSB-BP890552NDAA
CSB-MP890552NDAA
CSB-EP890552NDAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nephroselmis olivacea 30S ribosomal protein S2, chloroplastic (rps2) CSB-YP890553NDAA
CSB-EP890553NDAA
CSB-BP890553NDAA
CSB-MP890553NDAA
CSB-EP890553NDAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nephroselmis olivacea Ribonuclease E homolog (rne) CSB-YP890554NDAA
CSB-EP890554NDAA
CSB-BP890554NDAA
CSB-MP890554NDAA
CSB-EP890554NDAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nephroselmis olivacea ATP synthase subunit alpha, chloroplastic (atpA), partial CSB-YP890555NDAA
CSB-EP890555NDAA
CSB-BP890555NDAA
CSB-MP890555NDAA
CSB-EP890555NDAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nephroselmis olivacea 50S ribosomal protein L16, chloroplastic (rpl16) CSB-YP890556NDAA
CSB-EP890556NDAA
CSB-BP890556NDAA
CSB-MP890556NDAA
CSB-EP890556NDAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nephroselmis olivacea 30S ribosomal protein S11, chloroplastic (rps11) CSB-YP890557NDAA
CSB-EP890557NDAA
CSB-BP890557NDAA
CSB-MP890557NDAA
CSB-EP890557NDAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nephroselmis olivacea ATP synthase epsilon chain, chloroplastic (atpE) CSB-YP890558NDAA
CSB-EP890558NDAA
CSB-BP890558NDAA
CSB-MP890558NDAA
CSB-EP890558NDAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ligustrum vulgare NAD (P)H-quinone oxidoreductase subunit 5, chloroplastic (ndhF), partial CSB-YP890559LPO
CSB-EP890559LPO
CSB-BP890559LPO
CSB-MP890559LPO
CSB-EP890559LPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Photosystem II reaction center protein K (psbK), partial CSB-YP890560DZV
CSB-EP890560DZV
CSB-BP890560DZV
CSB-MP890560DZV
CSB-EP890560DZV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 50S ribosomal protein L4, chloroplastic (rpl4) CSB-YP890561DZV
CSB-EP890561DZV
CSB-BP890561DZV
CSB-MP890561DZV
CSB-EP890561DZV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 30S ribosomal protein S17, chloroplastic (rps17) CSB-YP890562DZV
CSB-EP890562DZV
CSB-BP890562DZV
CSB-MP890562DZV
CSB-EP890562DZV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 30S ribosomal protein S5, chloroplastic (rps5) CSB-YP890563DZV
CSB-EP890563DZV
CSB-BP890563DZV
CSB-MP890563DZV
CSB-EP890563DZV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 30S ribosomal protein S12, chloroplastic (rps12) CSB-YP890564DZV
CSB-EP890564DZV
CSB-BP890564DZV
CSB-MP890564DZV
CSB-EP890564DZV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytochrome c6 (petJ) CSB-YP890565DZV
CSB-EP890565DZV
CSB-BP890565DZV
CSB-MP890565DZV
CSB-EP890565DZV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant UPF0051 protein ycf24 (ycf24) CSB-YP890566DZV
CSB-EP890566DZV
CSB-BP890566DZV
CSB-MP890566DZV
CSB-EP890566DZV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>